HH
GILD icon

Hilltop Holdings’s Gilead Sciences GILD Stock Holding History

Hilltop Holdings’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.91M Sell
20,872
-8,156
-28% -$1.14M 0.26% 90
2025
Q4 		$3.56M Buy
29,028
+3,722
+15% +$452K 0.21% 119
2025
Q3 		$2.81M Sell
25,306
-94
-0.4% -$10.7K 0.15% 157
2025
Q2 		$2.82M Buy
25,400
+1,254
+5% +$133K 0.18% 136
2025
Q1 		$2.71M Buy
24,146
+935
+4% +$96.5K 0.17% 142
2024
Q4 		$2.14M Sell
23,211
-945
-4% -$85.1K 0.14% 172
2024
Q3 		$2.03M Buy
24,156
+269
+1% +$20.5K 0.13% 176
2024
Q2 		$1.64M Buy
23,887
+109
+0.5% +$7.27K 0.19% 141
2024
Q1 		$1.74M Sell
23,778
-938
-4% -$72.1K 0.18% 143
2023
Q4 		$2M Sell
24,716
-514
-2% -$40K 0.23% 126
2023
Q3 		$1.89M Buy
25,230
+815
+3% +$62.7K 0.22% 126
2023
Q2 		$1.88M Sell
24,415
-1,114
-4% -$88.8K 0.23% 115
2023
Q1 		$2.12M Buy
25,529
+642
+3% +$53.2K 0.28% 85
2022
Q4 		$2.14M Sell
24,887
-1,004
-4% -$79.5K 0.27% 88
2022
Q3 		$1.6M Buy
25,891
+1,881
+8% +$119K 0.22% 102
2022
Q2 		$1.48M Buy
24,010
+3,771
+19% +$233K 0.2% 111
2022
Q1 		$1.2M Sell
20,239
-4,659
-19% -$298K 0.14% 146
2021
Q4 		$1.81M Buy
24,898
+751
+3% +$51.7K 0.19% 117
2021
Q3 		$1.69M Buy
24,147
+616
+3% +$43.3K 0.18% 114
2021
Q2 		$1.62M Buy
23,531
+6,808
+41% +$455K 0.18% 119
2021
Q1 		$1.08M Sell
16,723
-3,802
-19% -$245K 0.14% 144
2020
Q4 		$1.2M Buy
20,525
+8,371
+69% +$505K 0.17% 139
2020
Q3 		$768K Sell
12,154
-9,548
-44% -$662K 0.13% 166
2020
Q2 		$1.67M Sell
21,702
-8,488
-28% -$650K 0.31% 75
2020
Q1 		$2.26M Buy
30,190
+14,156
+88% +$978K 0.54% 39
2019
Q4 		$1.04M Buy
16,034
+5,553
+53% +$362K 0.19% 128
2019
Q3 		$664K Buy
10,481
+2,464
+31% +$161K 0.13% 171
2019
Q2 		$541K Buy
8,017
+1,843
+30% +$121K 0.11% 180
2019
Q1 		$401K Sell
6,174
-71
-1% -$4.72K 0.09% 233
2018
Q4 		$390K Buy
6,245
+242
+4% +$16.9K 0.1% 206
2018
Q3 		$464K Buy
6,003
+1,422
+31% +$107K 0.1% 245
2018
Q2 		$325K Buy
4,581
+1,828
+66% +$129K 0.07% 297
2018
Q1 		$207K Sell
2,753
-750
-21% -$59.6K 0.04% 368
2017
Q4 		$250K Buy
3,503
+330
+10% +$25.1K 0.06% 295
2017
Q3 		$257K Buy
3,173
+185
+6% +$14.1K 0.08% 248
2017
Q2 		$211K Sell
2,988
-47
-2% -$3.13K 0.06% 297
2017
Q1 		$206K Sell
3,035
-32
-1% -$2.25K 0.06% 307
2016
Q4 		$219K Sell
3,067
-53
-2% -$3.94K 0.07% 295
2016
Q3 		$246K Sell
3,120
-240
-7% -$19.5K 0.08% 267
2016
Q2 		$280K Sell
3,360
-944
-22% -$83.8K 0.09% 235
2016
Q1 		$395K Sell
4,304
-708
-14% -$63.8K 0.12% 221
2015
Q4 		$507K Buy
5,012
+65
+1% +$6.76K 0.15% 183
2015
Q3 		$486K Buy
4,947
+75
+2% +$8.33K 0.14% 189
2015
Q2 		$571K Buy
4,872
+901
+23% +$98.5K 0.16% 174
2015
Q1 		$390K Buy
+3,971
New +$403K 0.1% 233
2014
Q3 		– Sell
-5,118
Closed -$424K – 210
2014
Q2 		$424K Sell
5,118
-49
-0.9% -$3.81K 0.2% 129
2014
Q1 		$366K Buy
5,167
+1,054
+26% +$82.7K 0.18% 138
2013
Q4 		$309K Buy
4,113
+109
+3% +$7.59K 0.16% 157
2013
Q3 		$252K Buy
+4,004
New +$239K 0.15% 164

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Hilltop Holdings's GILD Position: Q1 2026 in Review

Hilltop Holdings reduced its Gilead Sciences (GILD) stake by 28% in Q1 2026, selling an estimated $1.14M and leaving 20,872 shares worth $2.91M. The position accounts for 0.26% of the portfolio, ranked #90.

Hilltop Holdings first reported a position in GILD in Q3 2013 and has held it in 49 quarters since. The position peaked at $3.56M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Hilltop Holdings held 20,872 shares of Gilead Sciences worth $2.91M as of Q1 2026.
  • Hilltop Holdings sold 8,156 Gilead Sciences shares in Q1 2026, an estimated $1.14M.
  • Gilead Sciences made up 0.26% of Hilltop Holdings's portfolio in Q1 2026, its #90 holding.
  • Hilltop Holdings first reported a position in Gilead Sciences in Q3 2013 and has held it in 49 quarters since.
  • Hilltop Holdings's Gilead Sciences position peaked at $3.56M in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Hilltop Holdings's 13F filing for Q1 2026, filed 14 May 2026.